Author:
Shanmugam Srinivasan,Lee Eung Seok,Jeong Tae Cheon,Yong Chul Soon,Choi Han -Gon,Woo Jong -Soo,Yoo Bong Kyu
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference18 articles.
1. Belton, O., Byrne, D., Kearney, D., Leahy, A., and Fitzgerald, D., Cyclooxygenase-1 and-2-dependent prostacyclin formation in patients with atherosclerosis.Circulation, 102, 840–845 (2000).
2. Blank, J., Tucker, A., Sweatlock, J., Gasiewicz, T., and Luster, M., Alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlo-rodibenzo-p-dioxin-induced murine lymphocyte ethoxyre-sorufin-O-deethylase activity and immunosuppression.Mol. Pharmacol., 32, 169–172 (1987).
3. Burnier, M., The safety of rofecoxib. Expert Opin.Drug Saf., 4, 491–499 (2005).
4. Clark, D., Layton, D., and Shakir S., Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.Drug Saf., 27, 427–456 (2004).
5. Crespi, C., Miller, V., and Penman, B., Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.Anal. Biochem., 248, 188–90 (1997).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献